Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;413(1):33-8.
doi: 10.1007/BF00844279.

Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour

Affiliations

Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour

N Kimura et al. Virchows Arch A Pathol Anat Histopathol. 1988.

Abstract

Neuroendocrine cells have histologically common features represented by argyrophilic cytoplasm containing neuroendocrine granules. Neuroendocrine granules are composed of various kinds of peptide hormones, amines, carrier proteins and ATP. Although various kinds of peptide hormones have been detected in neuroendocrine tumours, a peptide hormone has not been required as a standard marker for these tumours. Chromogranin is a purified protein which binds catecholamines specifically and is recognized as a carrier protein. We carried out an immunohistochemical study of chromogranin immunoreactivity in 100 neuroendocrine tumours including pheochromocytomas, carotid body tumours, medullary thyroid carcinomas and carcinoid tumours. Marked immunoreactivity was observed in 85% of carcinoid tumours and 100% of the other tumour types. A non-functioning paraganglioma and a malignant carcinoid tumour without any other detectable marker also showed strong immunoreactivity to chromogranin. Chromogranin immunoreactivity is a useful tool for neuroendocrine tumours.

PubMed Disclaimer

References

    1. Am J Pathol. 1984 Sep;116(3):464-72 - PubMed
    1. Tanpakushitsu Kakusan Koso. 1984 Nov;29(12 Suppl):956-74 - PubMed
    1. Lab Invest. 1986 Oct;55(4):405-11 - PubMed
    1. J Histochem Cytochem. 1981 Apr;29(4):577-80 - PubMed
    1. Tohoku J Exp Med. 1984 Jan;142(1):1-14 - PubMed

MeSH terms

LinkOut - more resources